Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis.

Leong JY, Herrera-Caceres JO, Goldberg H, Tham E, Teplitsky S, Gomella LG, Trabulsi EJ, Lallas CD, Fleshner NE, Tilki D, Chandrasekar T.

Urology. 2019 Nov 6. pii: S0090-4295(19)30949-5. doi: 10.1016/j.urology.2019.10.012. [Epub ahead of print]

PMID:
31705947
2.

Incorporating mpMRI biopsy data into established pre-RP nomograms: potential impact of an increasingly common clinical scenario.

Leong JY, Herrera-Caceres JO, Goldberg H, Tham E, Teplitsky S, Gomella LG, Fleshner NE, Lallas CD, Trabulsi EJ, Chandrasekar T.

Ther Adv Urol. 2019 Oct 13;11:1756287219882809. doi: 10.1177/1756287219882809. eCollection 2019 Jan-Dec.

3.

Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram.

Weaver JK, Kim EH, Vetter JM, Shetty A, Grubb RL 3rd, Strope SA, Andriole GL.

Urology. 2018 Mar;113:119-128. doi: 10.1016/j.urology.2017.10.051. Epub 2017 Dec 5.

PMID:
29217354
4.

External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.

Gacci M, Schiavina R, Lanciotti M, Masieri L, Serni S, Vagnoni V, Abdollah F, Carini M, Martorana G, Montorsi F.

Urol Int. 2013;90(3):277-82. doi: 10.1159/000343993. Epub 2012 Dec 22.

PMID:
23296120
5.

A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A.

Eur Urol. 2019 Mar;75(3):506-514. doi: 10.1016/j.eururo.2018.10.012. Epub 2018 Oct 17.

PMID:
30342844
6.

Grade Group Underestimation in Prostate Biopsy: Predictive Factors and Outcomes in Candidates for Active Surveillance.

Audenet F, Rozet F, Resche-Rigon M, Bernard R, Ingels A, Prapotnich D, Sanchez-Salas R, Galiano M, Barret E, Cathelineau X.

Clin Genitourin Cancer. 2017 Dec;15(6):e907-e913. doi: 10.1016/j.clgc.2017.04.024. Epub 2017 Apr 26.

PMID:
28522288
7.

Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer.

Nason GJ, O'Connor EM, MacMahon D, Moss B, Considine SW, Cahill A, O'Rourke C, O'Brien FM.

Ir J Med Sci. 2018 Feb;187(1):33-37. doi: 10.1007/s11845-017-1626-8. Epub 2017 May 6.

PMID:
28478609
8.

One-Stop-Shop Whole-Body 68Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer.

Thalgott M, Düwel C, Rauscher I, Heck MM, Haller B, Gafita A, Gschwend JE, Schwaiger M, Maurer T, Eiber M.

J Nucl Med. 2018 Dec;59(12):1850-1856. doi: 10.2967/jnumed.117.207696. Epub 2018 May 24.

9.

Metastatic potential to regional lymph nodes with Gleason score ≤7, including tertiary pattern 5, at radical prostatectomy.

Diolombi ML, Epstein JI.

BJU Int. 2017 Jun;119(6):872-878. doi: 10.1111/bju.13623. Epub 2016 Sep 2.

10.

Do prostate cancer nomograms give accurate information when applied to European patients?

Turo R, Forster JA, West RM, Prescott S, Paul AB, Cross WR.

Scand J Urol. 2015 Feb;49(1):16-24. doi: 10.3109/21681805.2014.920415. Epub 2014 Jun 2.

PMID:
24882277
11.

Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.

Gandaglia G, Fossati N, Zaffuto E, Bandini M, Dell'Oglio P, Bravi CA, Fallara G, Pellegrino F, Nocera L, Karakiewicz PI, Tian Z, Freschi M, Montironi R, Montorsi F, Briganti A.

Eur Urol. 2017 Oct;72(4):632-640. doi: 10.1016/j.eururo.2017.03.049. Epub 2017 Apr 12.

PMID:
28412062
12.

A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.

Bandini M, Marchioni M, Preisser F, Nazzani S, Tian Z, Fossati N, Gandaglia G, Shariat SF, Montorsi F, Saad F, Briganti A, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2019 May;5(3):449-456. doi: 10.1016/j.euf.2017.11.013. Epub 2017 Dec 14.

PMID:
29249688
13.

First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy.

Bandini M, Marchioni M, Pompe RS, Tian Z, Gandaglia G, Fossati N, Abdollah F, Graefen M, Montorsi F, Saad F, Shariat SF, Briganti A, Karakiewicz PI.

BJU Int. 2018 Apr;121(4):592-599. doi: 10.1111/bju.14074. Epub 2017 Nov 29.

14.

Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.

Tosoian JJ, Chappidi M, Feng Z, Humphreys EB, Han M, Pavlovich CP, Epstein JI, Partin AW, Trock BJ.

BJU Int. 2017 May;119(5):676-683. doi: 10.1111/bju.13573. Epub 2016 Jul 29.

15.

Comparison between Briganti, Partin and MSKCC tools in predicting positive lymph nodes in prostate cancer: a systematic review and meta-analysis.

Cimino S, Reale G, Castelli T, Favilla V, Giardina R, Russo GI, Privitera S, Morgia G.

Scand J Urol. 2017 Oct;51(5):345-350. doi: 10.1080/21681805.2017.1332680. Epub 2017 Jun 23. Review.

PMID:
28644701
16.

Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection.

Hinev AI, Anakievski D, Kolev NH, Hadjiev VI.

Urol Int. 2014;92(3):300-5. doi: 10.1159/000354323. Epub 2014 Jan 25.

PMID:
24480972
17.

Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.

Rayn KN, Bloom JB, Gold SA, Hale GR, Baiocco JA, Mehralivand S, Czarniecki M, Sabarwal VK, Valera V, Wood BJ, Merino MJ, Choyke P, Turkbey B, Pinto PA.

J Urol. 2018 Nov;200(5):1041-1047. doi: 10.1016/j.juro.2018.05.094. Epub 2018 May 29.

PMID:
29852182
18.

External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients.

Hueting TA, Cornel EB, Somford DM, Jansen H, van Basten JA, Pleijhuis RG, Korthorst RA, van der Palen JAM, Koffijberg H.

Eur Urol Oncol. 2018 Oct;1(5):411-417. doi: 10.1016/j.euo.2018.04.016. Epub 2018 Jun 28.

PMID:
31158080
19.

Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.

Grivas N, Wit E, Tillier C, van Muilekom E, Pos F, Winter A, van der Poel H.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2213-2226. doi: 10.1007/s00259-017-3788-z. Epub 2017 Aug 5.

PMID:
28780722
20.

Development and comparison of a Chinese nomogram adding multi-parametric MRI information for predicting extracapsular extension of prostate cancer.

Chen Y, Yu W, Fan Y, Zhou L, Yang Y, Wang H, Jiang Y, Wang X, Wu S, Jin J.

Oncotarget. 2017 Mar 28;8(13):22095-22103. doi: 10.18632/oncotarget.11559.

Supplemental Content

Support Center